Femtech Insider

💰 AbbVie has announced the acquisition of Aliada Therapeutics for $1.4 billion in cash, strengthening its position in neuroscience drug development. The deal centers on Aliada's novel blood-brain barrier (BBB)-crossing technology and its lead Alzheimer's disease candidate, ALIA-1758, a development particularly significant given that women represent nearly two-thirds of Americans living with Alzheimer's disease. 🔬 💬 "Neuroscience is one of our key growth areas and we are committed to driving innovation in this field to address critical unmet needs for patients living with seriously debilitating neurological diseases such as Alzheimer's disease. This acquisition immediately positions us to advance ALIA-1758, a potentially best-in-class disease-modifying therapy for Alzheimer's disease." Roopal Thakkar, AbbVie Executive Vice President, Research and Development and Chief Scientific Officer #femtech #womenshealth #womenshealthinnovation #healthcare #healthcareinnovation #pharma #biotech #clinicaltrial #acquisition #alzheimers #brainhealth #healthyaging #drugdevelopment

🫀 The American Heart Association (AHA) is expanding its venture capital initiatives with a new $75 million fund focused specifically on women’s cardiovascular and brain health innovation. The new Go Red For Women Fund will target several key areas where women face unique health challenges. These include heart disease, stroke, kidney and metabolic conditions, mental health, and Alzheimer’s/dementia. The fund has also identified promising opportunities in conditions with strong cardiovascular implications, such as menopause, autoimmune disease, or PCOS. 💬 “The biggest opportunity lies in developing solutions that recognize and address the fundamental differences in how health conditions manifest and progress in women versus men. This includes everything from diagnostic differentiation to ensuring AI solutions are trained on appropriate gender-specific data." Lisa Suennen, GCB.D, AHA Ventures Managing Partner #femtech #womenshealth #femhealth #womenshealthinnovation #venturecapital #vc #ngo #investment #investor #fund #hearthealth #brainhealth #launch #healthcare #healthcareinnovation #medtech #healthtech #biotech #digitalhealth

🤝 Organon has announced the completion of its acquisition of Dermavant Sciences from Roivant, a deal first reported in September 2024. The completion comes at a strategic time, as the FDA reviews VTAMA cream’s potential expansion into atopic dermatitis treatment, with a decision expected in Q4 2024. 🔍 💬 "The future of dermatology depends on innovative treatments like VTAMA, and Organon’s acquisition of Dermavant allows us to further expand our existing portfolio of established brands and biosimilar dermatology treatments. Integrating the expertise of Dermavant into Organon’s U.S. organization marks the beginning of a new chapter in dermatology. We are excited to bring this nonbiologic non-steroidal topical option to the millions of patients suffering from a chronic skin condition like plaque psoriasis and, potentially in the future, atopic dermatitis.” Kevin Ali, Organon CEO #femtech #womenshealth #womenshealthinnovation #health #healthcare #healthtech #healthcareinnovation #pharma #dermatology #biotech #acquisition #ecosystem #drugdevelopment #regulatory #fda

💍 ŌURA has announced the addition of Fertile Window to its Cycle Insights feature, expanding its women’s health tracking capabilities. The feature leverages Oura’s existing temperature tracking capabilities, along with other biomarkers including heart rate, heart rate variability, and respiratory rate to predict and detect fertile days. 🤰 💬 "Understanding your fertile window is key to improving your body literacy, cycle awareness, and your overall reproductive health. One of the things I repeatedly hear from fertility clinicians is how stressful it is for their patients to actively track their fertile window. We created the Fertile Window feature to help minimize this stress with passive tracking and empower women through self-knowledge.” Neta Gotlieb, PhD, Women’s Health Senior Product Manager at ŌURA #femtech #womenshealth #womenshealthinnovation #health #healthcare #fertility #ovulation #reproductivehealth #ttc #infertility #fertilitytracking #pregnancy #wearables #feature #launch #healthtech #digitalhealth

🔬 Rallybio has received approval to begin testing a preventive treatment for a rare but serious pregnancy complication that affects mothers and their unborn babies. The condition, known as fetal and neonatal alloimmune thrombocytopenia (FNAIT), occurs when a pregnant woman’s immune system attacks her baby’s platelets, potentially causing dangerous bleeding in the fetus or newborn. 🤰 💬 "Securing these CTA approvals from European health authorities to advance RLYB212 into a Phase 2 clinical trial is a significant achievement. These approvals are a testament to the dedication and innovation of our team and our partners as we advance this first ever program to prevent maternal alloimmunization and FNAIT." Stephen Uden, Co-founder & CEO of Rallybio #femtech #womenshealth #womenshealthinnovation #biotech #pregnancy #healthtech #reproductivehealth #rarediseases #clinicaltrial #research

🤳 A fictional period tracking app called “RedWave” has emerged as part of a creative campaign to highlight reproductive rights concerns ahead of the 2024 election. The initiative comes from Creatives for Harris, a group of creative professionals organizing with their skills and time to support the Harris-Walz ticket. 🇺🇸 #femtech #womenshealth #womenshealthinnovation #data #dataprivacy #reproductiverights #healthcare #healthtech #digitalhealth #campaign #policy #election

🚀 The Advanced Research Projects Agency for Health (ARPA-H) has announced its first Sprint for Women’s Health awardees, investing $110 million across 23 projects focused on women’s healthcare. The initiative, which drew more than 1,700 submissions from over 30 countries, targets critical areas including brain health, reproductive health, and cardiovascular disease. 🔬 💬 "It’s been less than 10 months since we first launched the Sprint for Women’s Health where we asked for bold and transformative women’s health solutions. Now with these awardees, we are sprinting towards changing the lives of millions of women who have been left behind in research for far too long. It’s not just the great science we’re pursuing, but a different way of doing business in the government. Integral to the Sprint is to catalyze this ecosystem where we know there’s a huge market for women’s health." Renee Wegrzyn, Director of ARPA-H #femtech #womenshealth #womenshealthinnovation #femhealth #womenshealthresearch #funding #grant #research #science #breakthrough #brainhealth #athometesting #consumerhealth #chronicpain #endometriosis #ovarianbiology Celmatix Gravidas Diagnostics, Inc. Daré Bioscience, Inc. Glaucus Vanderbilt University Medical Center Aalto University Gameto Massachusetts General Hospital University of North Carolina at Chapel Hill GE Medical Systems, Ultrasound & Primary Care Diagnostics, LLC Monash University Tufts University California Institute of Applied Technology Wyss Institute at Harvard University Aspira Women's Health General Proximity Nura Health Ancilia Biosciences

Want to work in women's health? Here's your chance! 👇 Every Friday we share exciting opportunities from across the femtech and women's health innovation ecosystem. For more, visit our job board: https://lnkd.in/dK9gAiNy 🚀 Simplyhealth is looking for a Strategic Client Manager. 🚀 hims & hers is hiring a Lead Data Analyst, Product. 🚀 Carrot Fertility is looking for a Sr. Consultant Relations Director. 🚀 The George Washington University Hospital is hiring an RN - 3N OB/GYN. 🚀 Bayer is looking for a Senior Medical Science Liaison - Cardiorenal. 🚀 Delfina is hiring a Manager, Care Delivery. 🚀 Cambridge Health Alliance is hiring a Chief Development Officer. 🚀 Johns Hopkins Medicine is looking for a Registered Nurse - Maternal Fetal Medicine. 🚀 Kindbody is hiring a Paid Media Manager. 🚀 Ascension is looking for an RN Director - Women's Services. 🚀 CompHealth is hiring a Physician Reproductive Endocrinology and Infertility. 🚀 The Women's Hospital of Texas is hiring a Registered Nurse Antepartum. 🚀 Hologic, Inc. is hiring a Breast & Skeletal Health Marketing Manager. --- Want new jobs in the women's health ecosystem delivered straight to your inbox each week? Subscribe to our free Femtech Insider newsletter and never miss a beat! 👉 https://lnkd.in/dSPQJ53 #femtech #womenshealth #womenshealthinnovation #health #jobs #jobsearch #career #jobboard #womenshealthjobs #femtechjobs #healthcare #workinwomenshealth

💰 What will the future of family health and wellness look like? Panasonic Well is on a mission to find out and has launched a Family Wellness Innovation Challenge with $1M in equity-free prized up for grabs! Don't miss this opportunity to accelerate your growth and impact! 🚀 What to expect: 👇 ➡️ $1 Million in Equity-Free Prizes: Grand prize of $500,000 and four finalist prizes of $125,000 each. ➡️ Exclusive CES Showcase: Winners receive sponsored trips to CES and exhibition space alongside Panasonic, putting your innovation in the global spotlight. ➡️ Multiple Verticals: PanasonicWELL is looking for solutions across the family wellness spectrum. Your innovation could be the missing piece! ➡️ Networking Opportunities: Connect with industry leaders and potential partners in the Panasonic ecosystem and beyond. The challenge is open to startups worldwide with a U.S. entity and a product in the U.S. market. API integration experience is a plus! Applications close tomorrow. Check out the link below for more information about the challenge and how to apply! 👉 https://lnkd.in/gJYKsRQU #femtech #famtech #familytech #futurefamily #health #healthcare #wellness #challenge #grant #innovation #consumerhealth #healthtech #digitalhealth #healthcareinnovation #panasonic #corporateinnovation

🤝 Bayer has announced a partnership with deep-tech startup Impli to advance the development of what could become the first real-time hormone monitoring device. The collaboration aims to make fertility treatment more accessible, safer, and more successful while exploring broader applications of hormone monitoring technology. 🔬 💬 "Reimagining women’s hormonal health is more than a challenge; it’s an opportunity to innovate and transform lives. The opportunity to break barriers together with a pioneering leader in the field such as Bayer is not just exciting—it’s a chance to create meaningful change and deliver better outcomes for everyone." Anna Luisa Schaffgotsch Foudner & CEO of Impli #femtech #womenshealth #womenshealthinnovation #femhealth #hormonehealth #reproductivehealth #fertility #hormonemonitoring #medtech #deeptech #healthcare #healthtech #partnership